Merck & Co. Inc.’s reported positive results Tuesday for a new, easier-to-administer formulation of its blockbuster cancer ...

A study at MedUni Vienna's Department of Dermatology provides insights into the diversity of cancer-associated fibroblasts in ...

Wellness fanatics on social media are preaching that so-called 'toxic' sun cream shouldn't be worn year-round, but are these ...

From making skin cancer detection easier to making drone delivery safer, these companies are showing that good things can ...

California firefighters will be on the front lines of research aimed at combatting high rates of cancer among their ranks.

Merck's new formulation could help secure a larger share of Keytruda's sales after the cancer drug's U.S. patent expires in ...

A BEAUTY guru has revealed the anti-ageing treatment that she swears by after working in the industry for 20 years. Georgia ...

The mohs team at Chorley and Hospital. Lancashire Teaching Hospitals has launched a first-of-its-kind service in the region ...

Subcutaneous pembrolizumab matched IV Keytruda in key pharmacokinetic metrics in a Phase 3 NSCLC trial. Safety and efficacy ...

The residents of Delhi-NCR woke up to severe cold, haze, and 'hazardous' air quality on Tuesday, with most AQI stations ...

Analysts are split on whether the positive trial results will help Merck stem future Keytruda losses as the mega-blockbuster ...